Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas

Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.

Rakesh K. Jain · PubMed · 1990 · 577 citations

Tumor Biology, Tumor Immunology, Immunocytochemical Technique +15

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

Oliver W. Press, F. R. Appelbaum, Paul J. Martin et al. · The Lancet · 1995 · 432 citations

Lymphoid Neoplasia, Cell Therapy, Transplantation +11

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

Mark Kaminski, Kenneth Zasadny, Isaac R. Francis et al. · Journal of Clinical Oncology · 1996 · 401 citations

Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney

E. Oosterwdk, D. J. Ruiter, Ph. J. Hoedemaeker et al. · International Journal of Cancer · 1986 · 365 citations

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

Kenji Fujimori, David G. Covell, John Fletcher et al. · PubMed · 1990 · 359 citations

Immunocytochemical Technique, Immunology, Antibody Distribution +21